MD4581C1 - 2-{[(Prop-2-en-1-ylcarbamothioyl)hydrazino]methyl} pyridinium nitrate compound having human myeloid leukemia HL-60 cell proliferation inhibitor properties - Google Patents
2-{[(Prop-2-en-1-ylcarbamothioyl)hydrazino]methyl} pyridinium nitrate compound having human myeloid leukemia HL-60 cell proliferation inhibitor propertiesInfo
- Publication number
- MD4581C1 MD4581C1 MDA20170084A MD20170084A MD4581C1 MD 4581 C1 MD4581 C1 MD 4581C1 MD A20170084 A MDA20170084 A MD A20170084A MD 20170084 A MD20170084 A MD 20170084A MD 4581 C1 MD4581 C1 MD 4581C1
- Authority
- MD
- Moldova
- Prior art keywords
- myeloid leukemia
- ylcarbamothioyl
- hydrazino
- prop
- methyl
- Prior art date
Links
- 208000025113 myeloid leukemia Diseases 0.000 title abstract 3
- -1 2-{[(Prop-2-en-1-ylcarbamothioyl)hydrazino]methyl} pyridinium nitrate compound Chemical class 0.000 title abstract 2
- 230000004663 cell proliferation Effects 0.000 title abstract 2
- 239000003112 inhibitor Substances 0.000 title abstract 2
- 239000003814 drug Substances 0.000 abstract 1
- 150000002894 organic compounds Chemical class 0.000 abstract 1
- 150000003583 thiosemicarbazides Chemical class 0.000 abstract 1
Landscapes
- Pyridine Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention relates to chemistry and medicine, in particular to a biologically active organic compound of the thiosemicarbazide class and can be used for preventing and treating human myeloid leukemia.According to the invention, claimed is 2-{[(prop-2-en-1-ylcarbamothioyl)hydrazino]methyl} pyridinium nitrate compound of formula:which has human myeloid leukemia HL-60 cell proliferation inhibitor properties.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MDA20170084A MD4581C1 (en) | 2017-10-06 | 2017-10-06 | 2-{[(Prop-2-en-1-ylcarbamothioyl)hydrazino]methyl} pyridinium nitrate compound having human myeloid leukemia HL-60 cell proliferation inhibitor properties |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MDA20170084A MD4581C1 (en) | 2017-10-06 | 2017-10-06 | 2-{[(Prop-2-en-1-ylcarbamothioyl)hydrazino]methyl} pyridinium nitrate compound having human myeloid leukemia HL-60 cell proliferation inhibitor properties |
Publications (2)
Publication Number | Publication Date |
---|---|
MD4581B1 MD4581B1 (en) | 2018-07-31 |
MD4581C1 true MD4581C1 (en) | 2019-02-28 |
Family
ID=62974913
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MDA20170084A MD4581C1 (en) | 2017-10-06 | 2017-10-06 | 2-{[(Prop-2-en-1-ylcarbamothioyl)hydrazino]methyl} pyridinium nitrate compound having human myeloid leukemia HL-60 cell proliferation inhibitor properties |
Country Status (1)
Country | Link |
---|---|
MD (1) | MD4581C1 (en) |
-
2017
- 2017-10-06 MD MDA20170084A patent/MD4581C1/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
MD4581B1 (en) | 2018-07-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12017502363A1 (en) | Brk inhibitory compound | |
MX2020009347A (en) | Picolinamides as fungicides. | |
MX2018006287A (en) | Triazole acc inhibitors and uses thereof. | |
PH12017502407A1 (en) | Fused pyrimidine compound or salt thereof | |
MX2018006286A (en) | Pyrazole acc inhibitors and uses thereof. | |
MX2017009571A (en) | Heterocyclic itk inhibitors for treating inflammation and cancer. | |
MY196330A (en) | Diacylglycerol Acyltransferase 2 Inhibitors | |
MY196749A (en) | Eif4a-inhibiting compounds and methods related thereto | |
PH12016500225A1 (en) | Novel quinoline-substituted compound | |
SG11201901061QA (en) | Heterocyclic compound | |
AU2015374459A8 (en) | Picolinamide compounds with fungicidal activity | |
MX2016015743A (en) | Cyclopropylamine compounds as histone demethylase inhibitors. | |
PH12017500416A1 (en) | Compounds and compositions as raf kinase inhibitors | |
PH12016502130B1 (en) | Novel pyrrolopyrimidine compound or salt thereof, pharmaceutical composition containing same, especially agent for prevention and/or treatment of tumors etc based on nae inhibitory effect | |
MX2016013636A (en) | Novel nitrification inhibitors. | |
MX2020004374A (en) | Pharmaceutical composition for prevention or treatment of acute myeloid leukemia or metastatic breast cancer. | |
MD4215C1 (en) | Inhibitor of human myeloid leukemia based on N-(4-(5-(pyridin-2-yl)-4,5-dihydro-1H-pyrazol-3-yl)phenyl)-2-(pyridin-2-ylmethylen)-hydrazinecarbothioamide | |
MX2020011002A (en) | Combination comprising hdac inhibitor, lag-3 inhibitor and a pd-1 inhibitor or pd-l1 inhibitor for cancer treatment. | |
MD4581B1 (en) | 2-{[(Prop-2-en-1-ylcarbamothioyl)hydrazino]methyl} pyridinium nitrate compound having human myeloid leukemia HL-60 cell proliferation inhibitor properties | |
MD4407B1 (en) | Inhibitor of human myeloid leukemia HL-60 cells based on bis[N-(prop-2-en-1-yl)-2-(pyridine-2-ylmethylidene)hydrazinecarbothioamide]nickel(II) chloride hydrate | |
MD4402C1 (en) | Methyl-N'-[(2-hydroxynaphthalene-1-il)methylidene]-N-prop-2-en-1-ylhydrazonothioate, exhibiting antifungal activity against Candida albicans | |
MD4613B1 (en) | Ethyl-4-{2-[(pyridin-2-ylmethylidene)hydrazinocarbothioyl]amino benzoate monohydrate exhibiting properties of human myeloid leukemia HL-60 cell proliferation inhibitor | |
MD4349B1 (en) | N-(3-methoxyphenyl)-2-(pyridine-2-ylmethylene)-hydrazinecarbothioamide compound - inhibitor of human melanoma MeW-164 cell proliferation | |
PH12015502637A1 (en) | Benzothiophene compound | |
MD4614C1 (en) | Dichloro-[N-(3-methoxyphenyl)-2-(pyridine-2-ylmethylene)-hydrazinecarbothioamide]zinc and dichloro-[N-(4-methoxyphenyl)-2-(pyridine-2-ylmethylene)-hydrazinecarbothioamide]zinc as human myeloid leukemia HL-60 cell proliferation inhibitors |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG4A | Patent for invention issued | ||
KA4A | Patent for invention lapsed due to non-payment of fees (with right of restoration) | ||
MM4A | Patent for invention definitely lapsed due to non-payment of fees |